These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8468528

  • 1. Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma.
    Fazio S, Horie Y, Weisgraber KH, Havekes LM, Rall SC.
    J Lipid Res; 1993 Mar; 34(3):447-53. PubMed ID: 8468528
    [Abstract] [Full Text] [Related]

  • 2. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS, Fazio S, Lee YL, Mahley RW.
    J Biol Chem; 1994 Jan 28; 269(4):2764-72. PubMed ID: 8300609
    [Abstract] [Full Text] [Related]

  • 3. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U.
    Hum Genet; 1986 Jun 06; 73(2):157-63. PubMed ID: 3721502
    [Abstract] [Full Text] [Related]

  • 5. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.
    de Knijff P, van den Maagdenberg AM, Stalenhoef AF, Leuven JA, Demacker PN, Kuyt LP, Frants RR, Havekes LM.
    J Clin Invest; 1991 Aug 06; 88(2):643-55. PubMed ID: 1864973
    [Abstract] [Full Text] [Related]

  • 6. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR, van Luyn MJ, van Goor H, Bloks V, Apostel F, Greeve J, Hofker MH, Jong MC, van Vlijmen BJ, Havekes LM, Kuipers F.
    J Hepatol; 2000 Aug 06; 33(2):189-98. PubMed ID: 10952236
    [Abstract] [Full Text] [Related]

  • 7. Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
    Zhao SP, Smelt AH, Van den Maagdenberg AM, Van Tol A, Vroom TF, Gevers Leuven JA, Frants RR, Havekes LM, Van der Laarse A, Van 't Hooft FM.
    Arterioscler Thromb; 1994 Nov 06; 14(11):1705-16. PubMed ID: 7947593
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
    März W, Hoffmann MM, Scharnagl H, Fisher E, Chen M, Nauck M, Feussner G, Wieland H.
    J Lipid Res; 1998 Mar 06; 39(3):658-69. PubMed ID: 9548597
    [Abstract] [Full Text] [Related]

  • 9. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR.
    J Biol Chem; 1993 May 15; 268(14):10540-5. PubMed ID: 7683682
    [Abstract] [Full Text] [Related]

  • 10. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley RW.
    J Biol Chem; 1998 Oct 09; 273(41):26388-93. PubMed ID: 9756870
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.
    Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE.
    J Biol Chem; 1995 Nov 10; 270(45):27063-71. PubMed ID: 7592957
    [Abstract] [Full Text] [Related]

  • 13. Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells.
    Reardon CA, Blachowicz L, Watson KM, Barr E, Getz GS.
    J Lipid Res; 1998 Jul 10; 39(7):1372-81. PubMed ID: 9684739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH, de Beer F, van de Laarse A, Smelt AH, Leuven JA, Havekes LM.
    Atherosclerosis; 1998 Feb 10; 136(2):255-62. PubMed ID: 9543096
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F, van Dijk KW, Jong MC, van Vark LC, van der Zee A, Hofker MH, Fallaux FJ, Hoeben RC, Smelt AH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 2000 Jul 10; 20(7):1800-6. PubMed ID: 10894820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec 10; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.